189 related articles for article (PubMed ID: 29623632)
1. Out-of-Pocket Expenditures, Indirect Costs and Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Thailand.
Tanvejsilp P; Loeb M; Dushoff J; Xie F
Pharmacoecon Open; 2018 Sep; 2(3):281-296. PubMed ID: 29623632
[TBL] [Abstract][Full Text] [Related]
2. Healthcare Resource Uses and Out-of-Pocket Expenses Associated with Pulmonary TB Treatment in Thailand.
Tanvejsilp P; Loeb M; Dushoff J; Xie F
Pharmacoecon Open; 2018 Sep; 2(3):297-308. PubMed ID: 29623626
[TBL] [Abstract][Full Text] [Related]
3. Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand.
Tanvejsilp P; Pullenayegum E; Loeb M; Dushoff J; Xie F
J Clin Pharm Ther; 2017 Jun; 42(3):337-344. PubMed ID: 28317143
[TBL] [Abstract][Full Text] [Related]
4. Quality of life, out-of-pocket expenditures, and indirect costs among patients with the central nervous system tumors in Thailand.
Tunthanathip T; Sae-Heng S; Oearsakul T; Kaewborisutsakul A; Inkate S; Madteng S; Tanvejsilp P
J Neurosci Rural Pract; 2022; 13(4):740-749. PubMed ID: 36743773
[TBL] [Abstract][Full Text] [Related]
5. Identifying costs contributing to catastrophic expenditure among TB patients registered under RNTCP in Delhi metro city in India.
Sarin R; Vohra V; Singla N; Thomas B; Krishnan R; Muniyandi M
Indian J Tuberc; 2019 Jan; 66(1):150-157. PubMed ID: 30797274
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
Veesa KS; John KR; Moonan PK; Kaliappan SP; Manjunath K; Sagili KD; Ravichandra C; Menon PA; Dolla C; Luke N; Munshi K; George K; Minz S
PLoS One; 2018; 13(2):e0191591. PubMed ID: 29414980
[TBL] [Abstract][Full Text] [Related]
7. Contemporary relationship between medical expenditures and quality of life among adults with epilepsy in the United States.
Lekoubou A; Pelton M; Bishu KG; Ovbiagele B
Epilepsy Behav; 2020 Nov; 112():107430. PubMed ID: 32956943
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis.
Getahun B; Wubie M; Dejenu G; Manyazewal T
Infect Dis Poverty; 2016 Nov; 5(1):93. PubMed ID: 27799063
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Health-Related Quality of Life and Incurred Costs Among Human Immunodeficiency Virus, Tuberculosis, and Tuberculosis/HIV Coinfected Outpatients in Indonesia.
Idrus LR; Fitria N; Purba FD; Alffenaar JC; Postma MJ
Value Health Reg Issues; 2024 May; 41():32-40. PubMed ID: 38194897
[TBL] [Abstract][Full Text] [Related]
10. Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis: A Secondary Analysis of a Randomized Clinical Trial.
Manyazewal T; Woldeamanuel Y; Fekadu A; Holland DP; Marconi VC
JAMA Netw Open; 2022 Sep; 5(9):e2230509. PubMed ID: 36107429
[TBL] [Abstract][Full Text] [Related]
11. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
[No Abstract] [Full Text] [Related]
12. Out-of-pocket payments and economic consequences from tuberculosis care in eastern China: income inequality.
Liu Y; Xu CH; Wang XM; Wang ZY; Wang YH; Zhang H; Wang L
Infect Dis Poverty; 2020 Feb; 9(1):14. PubMed ID: 32019611
[TBL] [Abstract][Full Text] [Related]
13. Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis.
Mukherjee K; Kamal KM
Am Health Drug Benefits; 2017 Feb; 10(1):7-15. PubMed ID: 28465764
[TBL] [Abstract][Full Text] [Related]
14. Out-of-pocket costs and productivity losses in haemodialysis and peritoneal dialysis from a patient interview survey in Taiwan.
Tang CH; Chen HH; Wu MJ; Hsu BG; Tsai JC; Kuo CC; Lin SP; Chen TH; Sue YM
BMJ Open; 2019 Mar; 9(3):e023062. PubMed ID: 30904836
[TBL] [Abstract][Full Text] [Related]
15. Directly observed therapy for treating tuberculosis.
Karumbi J; Garner P
Cochrane Database Syst Rev; 2015 May; 2015(5):CD003343. PubMed ID: 26022367
[TBL] [Abstract][Full Text] [Related]
16. Assessing out-of-pocket expenses and indirect costs for the Alzheimer disease continuum in the United States.
Monfared AAT; Hummel N; Chandak A; Khachatryan A; Zhang Q
J Manag Care Spec Pharm; 2023 Sep; 29(9):1065-1077. PubMed ID: 37307097
[No Abstract] [Full Text] [Related]
17. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
[TBL] [Abstract][Full Text] [Related]
18. Managing Urban Stroke Health Expenditures in China: Role of Payment Method and Hospital Level.
Yang Y; Man X; Yu Z; Nicholas S; Maitland E; Huang Z; Ma Y; Shi X
Int J Health Policy Manag; 2022 Dec; 11(11):2698-2706. PubMed ID: 35219287
[TBL] [Abstract][Full Text] [Related]
19. Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health System.
Wong WWL; Wong J; Bremner KE; Saeed Y; Mason K; Phoon A; Feng Z; Feld JJ; Mitsakakis N; Powis J; Krahn M
Value Health; 2022 Feb; 25(2):247-256. PubMed ID: 35094798
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
